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Abstract 
Prolonged use of topical corticosteroids, particularly in infants, albeit rare, may 
lead to Cushing syndrome. Central nervous system abnormalities including 
brain atrophy and delayed myelination on cranial magnetic resonance imaging 
has been reported in patients with corticosteroid treatment. We herein report a 
5-month-old female infant referred to Department of Pediatric Endocrinology, 
Edirne, Turkey with brain atrophy and myelination delay that might be due to 
iatrogenic Cushing syndrome caused by topical corticosteroid use.
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Introduction:
Cushing syndrome (CS) is a rarely seen entity in childhood. Iatrogenic or exogenous 
CS due to chronic administration of glucocorticoids is the most common form of CS 
in children. Peroral or parenteral forms of glucocorticoids are more likely to cause 
CS than topical glucocorticoids (1). However, infants are more vulnerable to the 
side effects of topical glucocorticoids compared to older individuals because they 
have higher ratio of body surface area to body weight, and thinner skin barrier (2, 
3). Therefore, long term use of potent topical corticosteroids may lead to iatrogenic 
CS in infants (2-7). 
Brain atrophy has been reported in both pediatric and adult patients being treated 
with steroids with the indication of respiratory, rheumatological, and autoimmune 
diseases (8). Few cases have been reported regarding CS caused by topical steroid 
misuse (2-7). However, to our knowledge, associated imaging findings of brain 
atrophy and myelination delay have not been reported in children. 
We herein report a 5-month-old infant with brain atrophy and myelination delay 
associated with iatrogenic CS caused by topical corticosteroid use.
Case Report
A 5-month-old girl was referred to Department of Pediatric Endocrinology, Edirne, 
Turkey with the complaint of excessive weight gain (1300 g in one month). She 
was born at term as the first child of the family. Her birth and family history were 
otherwise unremarkable. Her birth weight, height, and head circumference were 
within normal limits. On physical examination her weight was 6.9 kg (50-75th 
percentile), length was 56.8 cm (3rd-10th percentile), and head circumference 
was 38.5 cm (3rd percentile). While body temperature was within normal limits, 
blood pressure was above the 95th percentile for this age group (135/102 mmHg). 
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Tachycardia and tachypnea were also present. She had 
cushingoid face, buffalo hump, truncal obesity, paperthin 
skin, and telengiectasies involving her face and body 
(Fig. 1).
Detailed history obtained from her mother revealed 
unprescribed usage of a topical steroid (clobetasol-17-
propionate) for diaper dermatitis for last two months 
in every diaper change with the recommendation of 
her grandmother. There was no history of any oral 
or parenteral medication. Laboratory data revealed 
trombocytosis (618000/mm3) and elevated levels of 
aspartate aminotransferase (104 UI/L). Basal serum 
cortisol and adrenocorticotropic hormone (ACTH) 
levels were low (0.8  µg/dL and 8.6 pg/mL, respectively) 
consistent with iatrogenic Cushing sydrome. To 
exclude tertiary adrenal insufficiency, low dose ACTH 
stimulation was performed. As 1 µg ACTH stimulation 
test was normal with maximum cortisol of 19.4 µg/
dL, tertiary adrenal insufficiency was excluded and 
hydrocortisone replacement therapy was not started. 
Other blood test results and urinalysis were within 
normal limits. Abdominal ultrasonography was normal 
except for grade 1 hepatosteatosis. On the seventh day of 
hospitalization she was presented with fever, fontanelle 
bulging, lethargy, feeding problems, and vomitting. 
On cranial magnetic resonance imaging (MRI) obtained 
to rule out the increased intracranial pressure, prominent 
intra- and extraaxial subarachnoid spaces and decreased 
cerebral volume consistent with brain atrophy were 
detected. Furthermore, delayed myelination was also 
encountered (Fig. 2). Leukocytosis was detected (11800/
mm3) on complete blood count. Although the lumbar 
puncture revealed a normal level of white blood cell 
count, lower cerebrospinal-to-serum glucose ratio was 
also noted. Thus, acute bacterial meningitis could not 
be excluded and intravenous ceftriaxone (100 mg/kg/
day) was started. Her symptoms resolved gradually. 
Antibiotherapy was continued for ten days although 
cerebrospinal fluid culture was negative. Subsequently, 
she was discharged with the advice of 1 month follow-
up. In the follow up controls, the Cushingoid appearance 
recovered completely at 9-month-old. When she reached 
one-year-old, she could stand on her own and started to 
walk, she could use spoon, she was able to hold a pen and 
scribble, understand and say some words. Therefore she 
was considered at the same level as her peers in terms of 
neuromotor development. The follow-up controls of the 
patient in healthy child polyclinic are ongoing. 
Informed consent was taken from her parents and the 
study was approved by Ethics Committee of the hospital.
Fig.1.Typical cushingoid face of the patient
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Discussion:
In current case, misuse of a potent topical corticosteroid 
for diaper dermatitis may be responsible for CS, brain 
atrophy, and delayed myelination. Iatrogenic CS caused 
by topical corticosteroid use is a rare entity that has been 
reported mostly in infants with diaper dermatitis (2, 7). 
The long term administration of topical corticosteroids 
with high potency to the skin covered with diaper or 
clothes are the risk factors that may cause systemic side 
effects like CS and adrenal suppression (7). Our patient 
had many of these risk factors. 
One of the most potent topical steriod, clobetasol-17-
propionate was applied after every diaper change for two 
months. In a study recruiting 18 children who had CS due 
to using nappy rash ointments, clobetasol was the most 
frequently used agent with the percentage of 73%. In this 
study, the duration of application of steroid including 
ointments was variable, with the period of at least 3 
weeks in one patient to more than 1 year in 3 patients. 
Another result of this study was the high rate (72% of 
the cases) of self medication (7). Self medication is a 
common public health problem in developing countries 
that may lead to severe health problems as discussed in 
this case. If necessary, these products should be used 
under the supervision of physicians and parents should 
be informed about the use and potential side effects of 
the drug. Furthermore, purchasing of these products from 
the drugstores without prescription should be prohibited.
There are also other systemic side effects of corticosterids 
apart from CS including hypertension, dyslipidaemia, 
adrenal insufficiency, failure to thrive, skin atrophy, 
striae, cataract, glaucoma, and predisposition to 
infections (3-6). At presentation, our patient had 
hypertension and findings indicating failure to thrive. 
Adrenal insufficiency was excluded in the light of 
normal low dose ACTH stimulation test. Furthermore, 
long-term application of the topical corticosteroid might 
have lead to tendency to infection that was considered as 
meningitis in our case. Our search for literature revealed 
a case of urinary infection and two cases of disseminated 
cytomegalovirus infection due to misuse of topical 
corticosteroid in children (4-6).
MRI abnormalities including brain atrophy and delayed 
myelination have been reported in both pediatric 
and adult patients being treated with corticosteroids 
(8). The evidence of dose-dependent brain atrophy 
and myelination delay was also shown in animal 
studies that investigated the side effects of antenatal 
administration of corticosteroids (9). The pathogenetic 
mechanisms of brain atrophy and myelination delay 
caused by chronic corticosteroid treatment is not 
well-known (8, 9). Glucocorticoids are thought to 
play inhibitory role in the neuronal maturation and 
myelination process by restraining the differentiation of 
oligodendrocyte precursors (9). Reduced glucose uptake 
in the brain, increased effects of excitatory amino acid 
neurotransmitters, decline in neurotrophic factors, and 
decrease in neurogenesis are deemed as mechanisms that 
account for brain atrophy (8). MRI is not only a very 
useful tool to show the details of brain anatomy without 
Fig.2.a-c. On coronal (a) and axial (b) T2W images, prominent intra- and extraaxial subarachnoid spaces and decreased cerebral 
volume consistent with brain atrophy are seen. Hyperintensity on T1W images resembling myelination is seen at posterior limbs 
of internal capsules and optic radiations (arrows). There are no evidence of T1 hyperintensities at the splenium of corpus callosum 
which is expected to be myelinated by the age of 4 months (dashed arrows) (c). Note the thickened subcutaneous fat in all series
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exposure to radiation, but also the best diagnostic 
modality to evaluate myelination of the developing brain 
(10). T1 is the most valuable sequence for demonstrating 
myelination in the first year of life, whereas T2-weighted 
(T2W) images provide additional information in later 
stages of myelin maturation. Myelinated white matter 
is seen hyperintense on T1-weighted (T1W) images 
consistent with increasing amount of cholesterol and 
galactocerebroside within myelin membranes, and 
hypointense on T2W images owing to reduced free water 
content between hydrophobic myelin sheats in maturing 
white matter (10). In our patient, normal myelination was 
only seen at bilateral perirolandic centrum semiovale, 
posterior limbs of internal capsules, optic radiations, 
brainstem, and deep cerebellar white matter on T1W 
images. Although the splenium of corpus callosum is 
expected to be myelinated and seen hyperintense on 
T1W images by the age of 4 months (10), there was 
no evidence of T1 hyperintensity at these areas in this 
5-month-old infant. Therefore delayed myelination was 
considered in addition to brain atrophy.
In conclusion, this is the unique case of iatrogenic CS 
with the findings of brain atrophy and delayed myelination 
demonstrated on MRI. The physicians should be well 
aware of potential systemic and neurodevelopmental 
side effects of topical steroids.
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